[ad_1]
New York, November 10, 2022 /PRNewswire/ — Revere Securities is pleased to announce that it acted as merger and acquisition advisor to Avalon Globalcare corp in its $31 million transaction. Avalon, a leading global developer of innovative cell-based technologies and therapeutics, has entered into a definitive acquisition agreement (“Acquisition contract”). In connection with the transaction, Avalon will change its ticker symbol from “AVCO” to “ALBT” to reflect its growing interest in lab testing and services. Avalon’s common stock will begin trading on the Nasdaq Capital Market under the new ticker symbol “ALBT.” November 10th2022.
About Avalon global care Ltd.
Avalon global care Corp. (NASDAQ: ALBT) is a leading clinical-stage, vertically integrated company dedicated to advancing and enhancing innovative and transformative immune effector cell therapies, exosome technologies, and cell therapy-related companion diagnostics. CellTech bio developer. Avalon also provides strategic advisory and outsourcing services to facilitate and strengthen clients’ growth and development and competitiveness in the healthcare and cell-tech industry markets. From innovative R&D to automated bioproduction to accelerated clinical development, Avalon provides cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX) through a uniquely integrated subsidiary structure across the industry. ™), and has established a leading role in the field of regenerative medicine. Therapeutics.
About Libya Securities
Revere Securities is a global broker-dealer firm providing strategic and financial support to institutional investors, hedge funds and individual investors. Our experts are involved in all components of the sales and trading process and include extensive compliance and operational personnel. In addition, Revere Securities LLC offers differentiated corporate access, helping institutional investors access management as part of the investment process. The company has industry-focused sales specialists with “buy-side” experience. It thus provides a healthy and alternative perspective to the investment process.
Media contact:
Jay You
Libya Securities LLC
(212) 688-2350
[email protected]
Source Revere Securities LLC
[ad_2]
Source link